The purpose of the present study is to assess the efficacy of methylprednisolone as an adjuvant therapy in patients with severe community-acquired pneumonia (CAP) (PSI 4-5). The hypothesis of the study is that methylprednisolone can decrease the mortality of severe CAP without any significant side effects,with reduction of the time to clinical stability and failure rate of treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
610
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
RECRUITINGAll cause mortality
Time frame: 30-days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.